2013 annual financial data
Travere Therapeutics 2013 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -23,972,073 USD and net income was -33,823,509 USD.
Operating cash flow was -17,589,168 USD.
Get free Travere Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- Not available
- Operating income
- -23,972,073 USD
- Net income
- -33,823,509 USD
- Operating cash flow
- -17,589,168 USD